Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Two additional MeSH terms related to glomerulonephritis were added to the Additional Relevant MeSH Terms section, potentially improving searchability.
    Difference
    0.1%
    Check dated 2026-04-03T05:53:03.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:42:50.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and notices about government funding lapse and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-12T02:09:56.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A government funding notice banner is displayed on the page, informing visitors of potential delays and status updates. The revision tag has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T12:45:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a glossary display and a new 'Last Update Submitted that Met QC Criteria' field. The footer now shows 'No FEAR Act Data' and a 'Revision: v3.4.0' indicator.
    Difference
    0.2%
    Check dated 2026-01-28T11:13:33.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be a metadata update with no impact on study details or content.
    Difference
    0.0%
    Check dated 2026-01-14T03:24:20.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.